Nabi Announces Plans To Evaluate Merger Or Sale Of Firm Under New CEO
This article was originally published in The Pink Sheet Daily
Executive Summary
Company refocuses on primary compounds, smoking-cessation vaccine NicVAX and Staphylococcus aureus vaccine StaphVax.